Position in LEGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,149,923
+$15,425,735 QoQ
Shares Held
663,086
+222.1% QoQ
Ownership
0.341%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#27
of 217 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. LEGN ranks #61 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in LEGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,149,923 | 663,086 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,724,188 | 205,870 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,458,373 | 205,077 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,687,560 | 205,077 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,278,182 | 205,077 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,867,036 | 113,971 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,914,692 | 120,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,330,818 | 109,395 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,429,044 | 100,001 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,609,392 | 100,007 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,017,000 | 100,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,717,000 | 100,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,687,124 | 169,305 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,338,036 | 131,440 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,937,232 | 138,967 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,365,200 | 131,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $64,407,805 | 1,171,051 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $42,555,993 | 1,171,051 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $68,920,622 | 1,478,666 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $74,757,712 | 1,478,594 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,208,415 | 273,043 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $12,148,730 | 431,418 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $8,250,553 | 193,857 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||